MedTrace Logo

Effects of Travoprost on Neovascular Glaucoma

NCT00441181 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2011-06-22

No results posted yet for this study

Summary

Prostaglandin analogues have not been used in the treatment of neovascular glaucoma because of suspicious lack of efficacy. This study aims at assessing the effect of travoprost on neovascular glaucoma.

Conditions

  • Neovascular Glaucoma

Interventions

DRUG

Travoprost

Sponsors & Collaborators

  • Federal University of São Paulo

    lead OTHER

Principal Investigators

  • Luiz A Melo Jr, MD · Federal University of São Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Completion
2008-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00441181 on ClinicalTrials.gov